Metacam 20 mg/ml 50 ml

Avertissement : le produit sur la photo peut différer du produit réel.

SKU
136322
Marque:
Boehringer Ingelheim
Batch:
S21061B-13
Expiry date:
31-12-2026
Numéro d'enregistrement:
NL: REG NL 9922

Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.

En stock

Composition

Meloxicam 20 mg/ml

Indication

Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
For use in diarrhoea, in combination with oral rehydration therapy, to reduce clinical signs in calves of over one week of age and young non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.

Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritisagalactia syndrome) with appropriate antibiotic therapy.

Horses:
For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic

Dosage and administration

- Cattle: Single subcutaneous or intravenous injection at a dose rate of 0.5 mg meloxicam/kg body weight (i.e. 2.5 ml/100 kg bodyweight) in combination with antibiotic therapy or with oral re-hydration therapy as appropriate.
- Pigs: Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 2.0 ml/100kg body weight) in combination with antibiotic therapy, as appropriate. If required, a second administration of meloxicam can be given after 24 hours.
- Horses: Single intravenous injection at a dosage of 0.6 mg meloxicam/kg bodyweight (i.e. 3.0 ml/100kg body weight). For use in the alleviation of inflammation and the relief of pain in both acute and chronic musculo-skeletal disorders, Metacam 15 mg/ml oral suspension may be used for continuation of treatment at a dosage of 0.6 mg meloxicam/kg body weight, 24 hours after administration of the injection.
Meloxicam 20 mg/ml
© 2024 Grovet B.V. All rights reserved.